Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Clinical trial NCT03689595 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT03689595
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-31
- Primary completion
- 2033-10-31
- Enrollment
- 30000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.